The ANGIODEFENDER^TM technology from Everist Health^TM provides a new approach to the world’s number one killer, cardiovascular disease (CVD). It is the world’s first prognostic device that combines sensor technology with a software algorithm to quickly and cost effectively assess the presence of early-stage CVD. Together with the Vascular Age Calculator, the ANGIODEFENDER^TM makes users aware of their cardiovascular risk by providing them with their heart’s age.